2 recruiting, 1 not yet recruiting, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Idiopathic Inflammatory Myopathies (IIMs): new trials by email Literature Review of Idiopathic Inflammatory Myopathies (IIMs) trials Research Report on Idiopathic Inflammatory Myopathies (IIMs)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases YTS109 cell - Systemic Lupus Erythematosus (SLE), Diffuse Systemic Sclerosis | Phase 1 | Not yet recruiting | Children's Hospital of Fudan University | 12 | 2026-03-01 | 2026-02-27 |
| Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory Myopathies Deucravacitinib 6mg po qd - Idiopathic Inflammatory Myopathies (IIMs) | Withdrawn | Peking University People's Hospital | 2025-10-05 | 2026-07-09 | ||
| AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. Allogeneic NK Cells - Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs) | Phase 2 | Recruiting | Artiva Biotherapeutics, Inc. | 90 | 2025-07-09 | 2026-07-31 |
Myositis (4) · Antiphospholipid Syndrome (2) · Arthritis, Rheumatoid (2) · Lupus Erythematosus, Systemic (2) · Scleroderma, Diffuse (2) · Scleroderma, Systemic (2) · Sjogren's Syndrome (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Axial Spondyloarthritis (1) · Granulomatosis with Polyangiitis (1) · Microscopic Polyangiitis (1) · Takayasu Arteritis (1)
Muscular Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Arthritis (3) · Autoimmune Diseases (3) · Connective Tissue Diseases (3) · Immune System Diseases (3) · Joint Diseases (3) · Rheumatic Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Cardiovascular Diseases (2) · Dry Eye Syndromes (2) · Eye Diseases (2)
Vaccines (1) · deucravacitinib (1)
Artiva Biotherapeutics, Inc. (1) · Children's Hospital of Fudan University (1) · Peking University People's Hospital (1) · University of Sao Paulo General Hospital (1)
Brazil (2) · China (2) · Bulgaria (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Portugal (1) · Romania (1) · Serbia (1) · Spain (1) · United States (1)